PFIZER, INC. |
Market Closed -
Other stock markets
|
After market 04:39:48 pm | |||
| 28.44 USD | +1.54% |
|
28.42 | -0.05% |
ETFs positioned on Pfizer, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.24% | 12 M€ | +11.92% | - | |
| 0.23% | 17 M€ | +4.26% | - | |
| 0.21% | 7 M€ | +5.61% | - | |
| 0.21% | 32 M€ | +1.38% | - | |
| 0.21% | 17 M€ | +5.61% | - | |
| 0.20% | 105 M€ | +3.54% | - | |
| 0.20% | 17 M€ | +2.80% | - | |
| 0.17% | 32 M€ | +0.82% | - | |
| 0.15% | 26 M€ | +16.85% | - | |
| 0.13% | 6 M€ | +3.89% | ||
| 0.11% | 2 M€ | +3.16% | - | |
| 0.11% | 115 M€ | +2.02% | - | |
| 0.10% | 54 M€ | +0.54% | - | |
| 0.10% | 8 M€ | +0.50% | - | |
| 0.10% | 756 M€ | -0.24% | - | |
| 0.09% | 6 M€ | -4.26% | - | |
| 0.07% | 7 M€ | +0.11% | - | |
| 0.05% | 11 M€ | +1.95% | - | |
| 0.03% | 34 M€ | +3.39% | - | |
| 23.95% | 129 M€ | +6.62% | - |
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.01
USD
Average target price
31.94
USD
Spread / Average Target
+14.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.22% | 159B | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.09% | 166B |
- Stock Market
- Equities
- PFE Stock
- Funds and ETFs Pfizer, Inc.